Identification of druggable cancer driver genes amplified across TCGA datasets.
The Cancer Genome Atlas (TCGA) projects have advanced our understanding of the driver mutations, genetic backgrounds, and key pathways activated across cancer types. Analysis of TCGA datasets have mostly focused on somatic mutations and translocations, with less emphasis placed on gene amplification...
Enregistré dans:
Auteurs principaux: | Ying Chen, Jeremy McGee, Xianming Chen, Thompson N Doman, Xueqian Gong, Youyan Zhang, Nicole Hamm, Xiwen Ma, Richard E Higgs, Shripad V Bhagwat, Sean Buchanan, Sheng-Bin Peng, Kirk A Staschke, Vipin Yadav, Yong Yue, Hosein Kouros-Mehr |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a29e5a4806f34d02a21d59875c6c8e59 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
KRAS mutation: from undruggable to druggable in cancer
par: Lamei Huang, et autres
Publié: (2021) -
On the reproducibility of TCGA ovarian cancer microRNA profiles.
par: Ying-Wooi Wan, et autres
Publié: (2014) -
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
par: Hamidreza Aboulkheyr Es, et autres
Publié: (2021) -
Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients.
par: Rosemary Braun, et autres
Publié: (2013) -
Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
par: Mark Manzano, et autres
Publié: (2018)